Bicoll, Genfit and the University of Freiburg began the OLNORME II program to develop candidates targeting an undisclosed nuclear orphan receptor

Bicoll Group

Germany / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Genfit S.A.

France / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

University of Freiburg

Germany / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced